These findings demonstrated that the commensal microbiome–acetate–FFAR2 molecular circuit improves insulin sensitivity in the liver and prevents the development of NAFLD/NASH. The gene discussed is FFAR2; the disease is metabolic dysfunction-associated steatohepatitis.